Selank & Semax* · Neuroactive Peptides*
Researchers seeking these products for laboratory research can explore PepGen-X.com as a supplier specializing in research-use compounds.
Selank and Semax are synthetic neuroactive peptides developed from naturally occurring peptide structures and extensively studied in Russia and Eastern Europe. Research has explored their effects on anxiety-related behavior, cognition, attention, neurotrophic signaling, stress responses, and neuroprotection.
Research Benefits
Selank* · TP-7*
Anxiety and stress research involving GABA-related and neuropeptide signaling
Cognitive research involving attention, memory, and learning
BDNF and neurotrophic signaling associated with neuronal function
Immune-modulation research related to its tuftsin-derived structure
Stress-response research involving adaptation to psychological and physiological stress
Semax* · ACTH(4-7)PGP*
Cognitive research involving memory, attention, and learning
BDNF and NGF research involving neurotrophic signaling and neuronal function
Neuroprotection research in models of neurological injury and ischemia
Stress and anxiety research involving central nervous system signaling
Neuroplasticity research examining mechanisms involved in neuronal adaptation
Identified Risks & Side Effects
Human clinical evidence remains limited compared with established CNS medications
Much of the published clinical research originates from Russia and Eastern Europe
Long-term safety of repeated exposure remains incompletely characterized
Individual responses may include fatigue, irritability, agitation, or other CNS effects
Not FDA-approved for human or veterinary use in the United States
Route: Experimental, commonly investigated by intranasal or subcutaneous administration | Frequency: Varies by research protocol | FDA Status: Not FDA-approved
Selank vs. Semax
Selank: A tuftsin-derived heptapeptide primarily investigated for anxiety, stress responses, cognition, immune signaling, and GABA-related pathways.
Semax: An ACTH-derived peptide primarily investigated for cognition, neuroprotection, neurotrophic signaling, and neurological recovery pathways.
Researcher Note
Selank and Semax represent two distinct approaches to neuroactive peptide research. Selank has received particular attention in anxiety, stress, and cognitive research, while Semax has been studied extensively in neuroprotection, cognition, and neurotrophic signaling. Both remain outside the FDA-approved therapeutic landscape in the United States, and much of the available clinical literature comes from Russia and neighboring countries.
Disclaimer
FDA Status: Not FDA-approved in the United States
Research Classification: Research use only
Compound Type: Synthetic neuroactive peptides
All products are intended strictly for research and laboratory use only and are not intended for human or veterinary use.